8FRR image
Entry Detail
PDB ID:
8FRR
Keywords:
Title:
Wild-type myocilin olfactomedin domain
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2023-01-08
Release Date:
2024-01-17
Method Details:
Experimental Method:
Resolution:
1.27 Å
R-Value Free:
0.15
R-Value Work:
0.13
R-Value Observed:
0.14
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Myocilin, C-terminal fragment
Chain IDs:A
Chain Length:259
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Competition between inside-out unfolding and pathogenic aggregation in an amyloid-forming beta-propeller.
Nat Commun 15 155 155 (2024)
PMID: 38168102 DOI: 10.1038/s41467-023-44479-2

Abstact

Studies of folded-to-misfolded transitions using model protein systems reveal a range of unfolding needed for exposure of amyloid-prone regions for subsequent fibrillization. Here, we probe the relationship between unfolding and aggregation for glaucoma-associated myocilin. Mutations within the olfactomedin domain of myocilin (OLF) cause a gain-of-function, namely cytotoxic intracellular aggregation, which hastens disease progression. Aggregation by wild-type OLF (OLFWT) competes with its chemical unfolding, but only below the threshold where OLF loses tertiary structure. Representative moderate (OLFD380A) and severe (OLFI499F) disease variants aggregate differently, with rates comparable to OLFWT in initial stages of unfolding, and variants adopt distinct partially folded structures seen along the OLFWT urea-unfolding pathway. Whether initiated with mutation or chemical perturbation, unfolding propagates outward to the propeller surface. In sum, for this large protein prone to amyloid formation, the requirement for a conformational change to promote amyloid fibrillization leads to direct competition between unfolding and aggregation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures